XML 133 R115.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Information - Schedule of Segment Information (Detail) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Segment Reporting Information [Line Items]                      
Net sales $ 755.4 $ 874.4 $ 916.5 $ 814.8 $ 903.0 $ 1,047.2 $ 1,021.7 $ 836.9 $ 3,361.1 $ 3,808.8 $ 3,767.2
Restructuring and divestiture costs                 23.3 19.8 20.8
Integration-related costs and other, net                 16.0 32.2 32.6
Goodwill impairment charge                 864.1 4.1 18.2
Depreciation and amortization                 248.5 244.5 216.8
Operating income (57.4) $ (811.3) $ 42.4 $ 15.4 21.7 $ 72.2 $ 65.8 $ (4.9) (810.9) 154.8 341.7
Interest expense                 (77.7) (75.8) (76.6)
Debt refinancing costs                 (3.2)   (78.5)
Foreign exchange loss                 (1.2) (0.6)  
Gain on acquisition of controlling interest                     25.9
Income from continuing operations before income taxes                 (893.0) 78.4 212.5
Capital expenditures                 196.7 202.5 189.0
Total assets 4,539.4       5,656.0       4,539.4 5,656.0 5,857.1
Chlorovinyls [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 2,506.1 2,930.2 2,917.3
Restructuring and divestiture costs                 0.3 12.6 (18.3)
Integration-related costs and other, net                 0.3 6.2 (8.8)
Goodwill impairment charge                 864.1 4.1 18.2
Depreciation and amortization                 205.8 200.3 174.2
Capital expenditures                 144.0 148.9 132.7
Total assets 3,909.4       4,872.0       3,909.4 4,872.0 5,074.0
Building Products [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 855.0 878.6 849.9
Restructuring and divestiture costs                 10.2 7.3 31.8
Integration-related costs and other, net                 0.6    
Depreciation and amortization                 31.9 34.5 35.7
Capital expenditures                 24.7 40.6 44.4
Total assets 557.7       581.3       557.7 581.3 577.8
Intersegment Elimination [Member] | Chlorovinyls [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 213.6 255.7 226.2
Intersegment Elimination [Member] | Building Products [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                   0.1 0.1
Intersegment Eliminations Unallocated and Other [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 (213.6) (255.8) (226.3)
Restructuring and divestiture costs                 12.8 (0.1) 7.3
Integration-related costs and other, net                 15.1 26.0 41.4
Depreciation and amortization                 (10.8) 9.7 6.9
Operating income                 (77.4) (84.9) (96.2)
Debt refinancing costs                 0.0   0.0
Capital expenditures                 28.0 13.0 11.9
Total assets $ 72.3       $ 202.7       72.3 202.7 205.3
Operating Segments [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 3,361.1 3,808.8 3,767.2
Operating Segments [Member] | Chlorovinyls [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 2,719.7 3,185.9 3,143.5
Operating income                 (768.5) 213.9 434.9
Operating Segments [Member] | Building Products [Member]                      
Segment Reporting Information [Line Items]                      
Net sales                 855.0 878.7 850.0
Operating income                 $ 35.0 $ 25.8 $ 3.0